Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001689375-22-000032
Filing Date
2022-09-28
Accepted
2022-09-28 17:08:56
Documents
1
Period of Report
2022-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166439931631699.html 4  
1 FORM 4 wf-form4_166439931631699.xml 4 5738
  Complete submission text file 0001689375-22-000032.txt   7122
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address
Dowden Nathan J (Reporting) CIK: 0001873392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 221276897